Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 11 studies | 32% ± 14% | |
goblet cell | 9 studies | 30% ± 9% | |
type I pneumocyte | 8 studies | 38% ± 14% | |
secretory cell | 7 studies | 27% ± 8% | |
club cell | 6 studies | 33% ± 7% | |
respiratory goblet cell | 6 studies | 42% ± 16% | |
squamous epithelial cell | 4 studies | 41% ± 21% | |
type II pneumocyte | 4 studies | 25% ± 7% | |
ciliated cell | 4 studies | 19% ± 4% | |
basal cell | 3 studies | 28% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2682.14 | 651 / 653 | 84% | 98.33 | 506 / 605 |
prostate | 97% | 1956.87 | 237 / 245 | 76% | 78.86 | 383 / 502 |
bladder | 100% | 3186.38 | 21 / 21 | 71% | 199.66 | 358 / 504 |
stomach | 84% | 13671.69 | 302 / 359 | 66% | 65.70 | 189 / 286 |
lung | 100% | 1769.21 | 577 / 578 | 49% | 41.07 | 567 / 1155 |
intestine | 46% | 1894.56 | 449 / 966 | 64% | 76.27 | 337 / 527 |
ureter | 0% | 0 | 0 / 0 | 100% | 384.40 | 1 / 1 |
kidney | 90% | 325.18 | 80 / 89 | 10% | 9.38 | 86 / 901 |
breast | 78% | 378.23 | 359 / 459 | 21% | 10.67 | 235 / 1118 |
pancreas | 8% | 26.43 | 27 / 328 | 90% | 203.87 | 161 / 178 |
esophagus | 49% | 440.19 | 711 / 1445 | 36% | 41.85 | 66 / 183 |
uterus | 54% | 188.22 | 92 / 170 | 27% | 25.78 | 123 / 459 |
blood vessel | 57% | 157.69 | 764 / 1335 | 0% | 0 | 0 / 0 |
adipose | 57% | 219.12 | 684 / 1204 | 0% | 0 | 0 / 0 |
ovary | 10% | 28.23 | 18 / 180 | 37% | 20.87 | 158 / 430 |
heart | 44% | 114.92 | 379 / 861 | 0% | 0 | 0 / 0 |
liver | 14% | 36.27 | 32 / 226 | 13% | 8.55 | 54 / 406 |
spleen | 24% | 55.59 | 58 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 22% | 57.84 | 208 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 10.63 | 13 / 258 | 15% | 9.22 | 35 / 230 |
brain | 10% | 19.76 | 257 / 2642 | 0% | 0.07 | 3 / 705 |
skin | 7% | 15.76 | 135 / 1809 | 1% | 0.34 | 5 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.94 | 2 / 45 |
muscle | 1% | 1.91 | 8 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
Gene name | VSIG2 |
Protein name | V-set and immunoglobulin domain-containing protein 2 (Cortical thymocyte-like protein) (CT-like protein) |
Synonyms | UNQ2770/PRO7154 CTXL CTH |
Description | |
Accessions | ENST00000326621.10 [Q96IQ7-1] Q96IQ7 ENST00000403470.1 [Q96IQ7-2] |